Comings And Goings In The Executive Branch – FDA And NIH

There’s appointments news to pass along.

First a departure of note, as much for where the person is going as where he’s been. Tom Insel is leaving the National Institute of Mental Health (NIMH) after 13 years as its director.  He is leaving to join Life Sciences, a company recently created by Google (and now part of its Alphabet holding company) to consolidate its various life science projects.  Insel will lead the company’s mental health efforts.  Bruce Cuthbert will take over as acting director of the NIMH until a replacement is name..

The Administration has finally announced a nominee to replace departed Food and Drug Administration (FDA) Commissioner Margaret Hamburg.  Rob Califf, currently Deputy Commissioner for Medical Products and Tobacco at the FDA, has been nominated, and might actually get confirmed in time for the next President to take office.  Prior to joining the FDA Califf has worked for over 30 years at the Duke Medical School and Duke University Medical Center.  He also founded the Duke University Clinical Research Institute and served as its Director.

In this completely arbitrary guess at when Califf might get confirmed, I’ll note it has been over six months since Commissioner Hamburg left, and it will probably take at least that much time for the Senate to hold a confirmation hearing and eventually vote on the nomination.

Advertisements

One thought on “Comings And Goings In The Executive Branch – FDA And NIH

  1. Pingback: Confirmation And Nomination News, Non-Scalia Edition | Pasco Phronesis

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s